All posts tagged Stem Cell
Groundbreaking Discovery Of Cell Nucleus Structure Crucial To Understanding Diseases
Genes relocated from their correct position in the nucleus cause them to malfunction and this may lead to the heart, blood vessels and muscles breaking down. This new discovery by A*STAR scientists may be the key to finding new cures …
BioRestorative (BRTX): Two Huge Markets, One Solid Business Model
BioRestorative Therapies Inc. (OTCQB: BRTX), an emerging leader in autologous adult stem cell treatments for the disc/spine, metabolic disorders, and obesity, operating alongside companies like Pluristem Therapeutics Inc.
Bone marrow holds key to stem cell breakthrough
PATIENTS suffering from spinal cord injury may soon find help in the form of stem cells drawn from their own bone marrow, thanks to a research project from
Stem Cells in Sports Injuries: A Performance Enhancement? Not Reimbursable? C’mon Man!
By: Jeff Chandler, Sports Medicine Writer at OrthoSpineNews.com Have you had enough? Let’s see, the last time I checked I thought that Doctors were to supposedly “best” treat our
BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure
JUPITER, Fla., Jan. 31, 2012 /PRNewswire/ -- BioRestorative Therapies, Inc. (OTCQB: BRTX) ("BRT") today announced that it has entered into a License Agreement with Regenerative Sciences, LLC ("RS") with respect to
Geron Selling Off Embryonic Stem Cell Technology
After nearly $450 million of equity raised and a record breaking $40 million FDA submission, Geron is throwing in the towel regarding its ground breaking embryonic stem cell
OrthoPathways Group, Inc. (OPG) Announces New, Novel Instrument Named Bio-Aug FX
Sarasota, FL, November 18, 2010 --(PR.com)-- As OrthoPathways Group, Inc. (OPG) continues to pursue new technologies to aid the orthopedically challenged patient, the company reports that they
Cytori Issued Celution(R) System Patent for Orthopedic & Spinal Disc Diseases
SAN DIEGO, Aug 12, 2010 (BUSINESS WIRE) -- Cytori Therapeutics (CYTX 4.69, +0.13, +2.88%) has received U.S. Patent No. 7,771,716 (the '716 patent) for Celution(R) System based methods
Cytori Therapeutics wins new Celution system patent for spinal disc disease
Cytori Therapeutics, a developer of medical products and devices, has received USpatent for Celution system based methods of treating musculoskeletal disorders such as
Stem cell therapy may end joint replacement
By Richard Alleyne, The Telegraph July 13, 2010 A stem cell therapy for osteoarthritis that could revolutionize its treatment is to be tested on patients for the first time in
Starting of the European project REBORNE aiming at bone defects regeneration using stem cells and biomaterials
10 Jun 2010 - Submitted by the end of 2008, the project REBORNE for 'Regenerating Bone defects using New biomedical Engineering approaches' has been accepted by the European Commission
Osiris Therapeutics Receives FDA Orphan Drug Designation for Stem Cell Treatment for Type 1 Diabetes
COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for
Biologic Joint Reconstruction Using Stem Cells Proven Successful In Patients With Arthritis
San Francisco, CA (PRWEB) March 23, 2010 -- Biologic Joint Reconstruction, rather than bionic (artificial) replacement, may be an appropriate first step for many people with
Stem Cell Cures Any Closer?
Twelve years after the discovery of the human embryonic stem cell, research is finally picking up steam. Over the past 7 years, the National Institutes of Health have
Modified Adult Stem Cells May Be Helpful in Spinal Cord Injury
ScienceDaily (Feb. 24, 2010) — Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical